FINWIRES · TerminalLIVE
FINWIRES

Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says

By

Perspective Therapeutics' (CATX) NET program to potentially treat neuroendocrine tumors may be advancing toward a potential phase 3 trial initiation, with sites to become "active" by the end of 2026 and data expected in October, RBC Capital Markets said in a note emailed Tuesday.

RBC said it hopes the data will include an efficacy cut that will allow a stock inflection as well as alignment with the US Food and Drug Administration.

Meanwhile, the investment firm noted that Perspective Therapeutics' other studies are also continuing to advance, with the PSV359 dosing program "recruiting quickly" even though it is facing some data delays.

RBC said Perspective Therapeutics is "70% likely to deliver positive data that can inflect shares" and allow phase 3 advancement and $480 million in 2035 royalties for the company from the NET program alone.

Perspective Therapeutics' shares are "significantly undervaluing the strength of the NET data and are trading at a discount to other radiopharma peers, and we would be buyers into 4Q catalysts," the note said.

RBC has an outperform rating, speculative risk, and $14 price target on Perspective Therapeutics.

Price: $3.07, Change: $+0.07, Percent Change: +2.17%

Related Articles

Wire

Fermi Signs First Binding Lease Agreement at Project Matador in Texas; Shares Rise After Hours

Fermi (FRMI) said late Monday it has signed its first binding customer lease at its Project Matador campus in Texas, a deal expected to generate about $6.5 billion over its initial 15-year term for the first phase.The lease between Fermi's subsidiary Fermi Campus 1 and TensorWave TEX1, a unit of TensorWave, covers a facility supported by 222 megawatts of total power once the final delivery phase begins.The agreement includes expansion rights for two additional data centers that would bring the partnership to more than 650 MW if exercised.Project Matador's first power is targeted for 2026, with construction already underway and permits secured for about 6 GW of the planned 17-GW campus.Fermi shares jumped 19% in after-hours trading.

$FRMI
Wire

Everpure Secures Second Hyperscaler Design, Supply Agreement; Shares Rise After Hours

Everpure (P) secured a second design and supply contract with an undisclosed top-five hyperscaler.The first contract was announced in late 2024 and uses Everpure's advanced software-powered DirectFlash technology to optimize hyperscale storage.The latest contract will be a "significant contributor to future revenue" starting in fiscal 2028, the company said Monday in a statement.Everpure shares rose 7.7% in after-hours trading.

$P
Wire

Upwork Q2 Adjusted Earnings Rise, Revenue Declines; Shares Fall After-Hours

Upwork (UPWK) reported Q2 non-GAAP earnings late Monday of $0.41 per diluted share, up from $0.35 a year earlier.Analysts polled by FactSet expected $0.34.Revenue for the quarter ended June 30 was $191.7 million, down from $194.9 million a year earlier.Analysts expected $189.9 million.The company expects Q3 non-GAAP EPS of $0.31 to $0.33 on revenue of $176 million to $184 million. Analysts expect $0.41 and $193.8 million, respectively.The company now expects 2026 non-GAAP EPS of $1.38 to $1.43 on revenue of $730 million to $750 million. It previously expected non-GAAP EPS of $1.50 to $1.55 on revenue of $760 million to $790 million.Analysts expect $1.54 and $776.0 million, respectively.Upwork shares fell over 21% in after-hours trading.

$UPWK